TY  - RPRT
TI  - A bayesian reanalysis of the phase III aducanumab (ADU) trial
AU  - Tommaso Costa
AU  - Franco Cauda
PY  - 2021
UR  - https://arxiv.org/abs/2107.03686
ID  - 2107.03686
ER  -